First Trust Germany AlphaDEX Fund (FGM)

The First Trust Germany AlphaDEX Fund, listed under the ticker FGM, is an exchange-traded fund that provides exposure to German equities selected through a quantitative scoring system called AlphaDEX, designed to identify stocks that may deliver superior risk-adjusted returns relative to traditional market-cap-weighted German indices.

The emergence of factor-based indexing

First Trust Advisors, a seasoned fund manager with deep roots in the exchange-traded fund space, launched FGM to bring systematic, factor-based investing to investors seeking German stock market exposure. The AlphaDEX approach represented a shift away from simple market-cap weighting — where the largest companies dominate the index — toward a methodology that ranks stocks on specific financial characteristics believed to correlate with outperformance.

This broader category, sometimes called smart beta or factor investing, gained traction in the early 2010s as researchers documented that certain company characteristics — such as relative cheapness, strong growth trajectories, or financial quality — had historically been associated with better long-term returns. FGM brought this thinking specifically to the German market, allowing investors to bet on these factors within a single geography rather than across all developed economies.

The AlphaDEX methodology in practice

FGM’s holdings come from the NASDAQ AlphaDEX Germany Index, which starts with the NASDAQ Germany Index as its base universe. From that base, the AlphaDEX screening process ranks stocks on two separate sets of criteria: growth factors and value factors.

On the growth side, the index evaluates recent price appreciation, the sales-to-price ratio, and one-year sales growth. Stocks with high growth momentum and cheap valuations relative to sales are favoured. On the value side, the index examines the book value-to-price ratio, cash flow-to-price ratio, and return on assets. Companies with strong profitability relative to shareholder equity and cheap valuations relative to their cash generation are ranked highly. The index then selects stocks with the highest combined scores and weights them accordingly, affording larger weightings to the strongest scoring names.

This hybrid approach attempts to capture both growth and value opportunities within German equities. It is not a pure growth fund nor a pure value fund; it blends the two philosophies and lets the quantitative scoring determine which stocks qualify.

FGM and German economic exposure

By investing in German equities, FGM provides exposure to an economy that has long been central to European manufacturing, engineering, and finance. Germany has historically hosted significant automotive, industrial machinery, pharmaceutical, and chemical sectors. The fund’s holdings reflect the composition of the German stock market at any given time, so readers who purchase FGM are effectively making a bet on the German economy’s health and the performance of the companies that dominate it.

Currency risk is inherent: FGM holdings are denominated in euros, so investors who pay in U.S. dollars are exposed to the euro-dollar exchange rate. If the euro weakens relative to the dollar, fund returns will be dampened; if the euro strengthens, returns are enhanced.

Fund structure and costs

FGM is a passively managed fund that tracks the NASDAQ AlphaDEX Germany Index. The fund is not actively managed in the traditional sense — no portfolio manager is making tactical calls to over- or under-weight stocks. Instead, the fund holds the index constituents and rebalances periodically according to the AlphaDEX rules. This passive approach keeps costs lower than active management would.

The fund’s expense ratio is modest, reflecting this index-tracking design. FGM is classified as an ordinary diversified fund, meaning it must hold a wide array of securities and no single holding can represent an outsized fraction of assets.

Risks specific to German equities and smart-beta methodology

FGM’s returns depend entirely on the performance of German stocks. If the German economy enters recession, if automotive or industrial demand collapses, or if regulatory changes constrain businesses in sectors where the fund has heavy exposure, FGM’s value will decline accordingly.

The AlphaDEX methodology itself carries a specific risk: the factors the system uses to score stocks — growth momentum, sales growth, return on assets — work well in some market environments and poorly in others. In a period when expensive growth stocks and weak profitability prevail, the AlphaDEX screen may lead to underperformance. Similarly, if the German market undergoes a sector rotation that favours financial stocks over industrials, or vice versa, the scoring system’s effectiveness may be temporarily impaired.

Concentration risk exists because the German stock market is smaller than those of the United States or many other developed nations. A smaller universe of stocks means the top holdings can represent a meaningful fraction of the fund.

Researching and evaluating FGM

The fund’s prospectus, available from First Trust or through SEC filings, describes the AlphaDEX methodology in detail and lists the securities that comprise the index. The NASDAQ website provides the official index composition and the detailed scoring criteria used in the selection process.

Potential investors should examine how FGM has performed in different German market environments — periods of strong export demand, weak demand, and sector rotations. Comparing FGM’s returns to a simple, market-cap-weighted German ETF shows whether the AlphaDEX factor approach is adding value or detracting from it. The fund’s expense ratio should be compared to other German equity funds and to the broader category of factor-based ETFs to assess whether the fee is reasonable for the strategy offered.

FGM is best suited to investors with specific interest in German equities who believe that the AlphaDEX factor approach will outperform traditional indexing, and who are comfortable with the currency risk and sector concentration inherent in a single-country fund.